Endometrial Cancer: A Patient Guide

Endometrial cancer is a condition that begins in the endometrium, the inner lining of the uterus. It is the most common gynecologic cancer in high-income countries. Because it frequently presents early with a clear warning sign—abnormal uterine bleeding, particularly after menopause—most patients are diagnosed when the cancer is confined to the uterus, where it is often highly treatable ^[1][2].

In recent years, the standard of care has been transformed by molecular profiling. In addition to looking at how cancer cells appear under a microscope, your care team will likely analyze the tumor’s genetic “fingerprint.” Tumors are typically categorized into one of four specific groups: POLE-mutated, MMR-deficient (MMRd), p53-abnormal, or No Specific Molecular Profile (NSMP). This modern approach provides a much more precise understanding of the disease, helping doctors identify which early-stage tumors are low-risk and may require less intensive treatment, and which have a higher risk of recurrence and need a more proactive strategy ^[3][4].

The foundational treatment for endometrial cancer is surgery, which is often performed using minimally invasive techniques to remove the uterus, tubes, and ovaries and to assess the lymph nodes. For many patients with localized disease, surgery may be the only treatment required. However, for those with more advanced or recurrent cancer, the landscape has changed dramatically. The integration of immunotherapy with traditional chemotherapy has provided new options that help the body’s own immune system recognize and attack cancer cells, improving outcomes for appropriately selected patients ^[5][6].

A cancer diagnosis is naturally a source of profound anxiety. While recurrence, treatment complications, and uncertainty remain possibilities, the care system is increasingly equipped to personalize your treatment. Between the high rates of early detection, the precision of molecular staging, and the continuous advancement of targeted therapies, your medical team will use these tools to tailor a care plan specific to your tumor’s biology, aiming to treat the disease while supporting your long-term health and quality of life ^[7].